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The reduction of the following exogenous quinones considered to act as
a mobile electron carrierbetween NADHby succinate and NADH was studied in mitochondria ubiquinone (Q)’ oxidoreductase (complex I), succinate-Q oxisolated from both wild type and ubiquinone (Q)-defi- idoreductase (complex 11), other primary dehydrogenases and
cient strains of yeast: ubiquinone-0 (Q,,),ubiquinone-1 ubiquinol (QH&cytochrome c oxidoreductase (complex 111).
(Q1), ubiquinone-2 (Q2), and its decyl analogue 2,3- In support of this view, Kroger and Klingenberg (1) demondimethoxy-5-methyl-6-decyl-1,4-benzoquinone
(DB), strated that 80-90% of the ubiquinone (Q) pool is homogeduroquinone (DQ), menadione (MQ), vitamin K1 (2- neous such that each ubiquinone molecule rapidly reaches
methyl-3-phytyl-1,4-naphthoquinone),
the plastoqui- and interacts with manydehydrogenase and cytochrome b-cl
none analogue 2,3,6-trimethyl-1,4-benzoquinone complex molecules. Recent studies in Hackenbrock’s labora(PQocl),plastoquinone-2 (PQ2),and its decyl analogue tory (2, 3) have also provided convincing evidence that the
(2,3-dimethyl-6-decy1-1,4-benzoquinone).
Reduction
respiratory chain complexes as well as ubiquinone are free to
of the smallquinones DQ, 80,Ql, and PQo,l by NADH
occurred in both wild type and Q-deficient mitochon- diffuse laterally and independentlyof each other in the plane
dria in a reaction inhibited more than 50% by myxo- of the mitochondrial membrane.
On the other hand, the
idea that ubiquinone can be reduced
thiazol and less than 20% by antimycin. The reduction
through
direct
interaction
between the primary dehydrogenof these small quinones by succinate also occurred in
cytochrome b-c, complex has also beensuggested.
wild type mitochondria in a reaction inhibited more ases and the
than 50% by antimycin but did not occur in Q-deficient Such a direct interaction was implicated initially in the Q
mitochondria suggesting that endogenous QB is in- cycle in which succinate dehydrogenase was proposed t o dovolved in their reduction. In addition, the inhibitory nate an electron at center i to form ubiquinol (4).Several
effects of antimycin and myxothiazol, specific inhibi- types of experimental evidence have provided evidence for the
tors of the cytochrome b-cl complex, on the reduction direct interactionof the complexes. For example, the sensitivof these small quinones suggest the involvement of this ity to antimycinof duroquinone (DQ) reduction by succinate
complex in theelectron transfer reaction. By contrast, implies the possibility of a direct interaction between succithe reduction of Qzand DB bysuccinate was insensitivenate-Q oxidoreductase and center i of the cytochrome b-c,
to inhibitors andby NADH was 20-30% inhibited by complex ( 5 , 6). Similarly, Ragan and Heron (7, 8) proposed
myxothiazol suggesting that these analogues are di- that electron transfer can
occur in a complex 1-111 “supercomrectly reduced by the primary dehydrogenases. The plex” based on the kineticsof electron transferfrom isolated
dependence of the sensitivity to the inhibitors on the complex I to complex 111. Interestingly, pool kinetics can still
substrate used suggests that succinate-ubiquinone ox- be realized in this systemif complex I and 111 can move freely
idoreductase interacts specifically with center i (the
dependence of the ubiquinol
antimycin-sensitive site) and NADH ubiquinone oxi- around each other. From the
oxidation
capacity
(V,)
of
the
respiratory
chain on the subdoreductase preferentially with center o (the myxothiazol-sensitive site) of the cytochrome b-el complex. strate used, Zhu et al. (9) concluded that both the free movecollision between
The NADH dehydrogenase involved in the myxothia- ment of ubiquinone molecules and the direct
zol-sensitive quinone reduction faces the matrix side ubiquinone-reducing and ubiquinol-oxidizingenzymesmay
of the inner membrane suggesting that center o may play a role in electron transfer through theQ pool.
Further evidence for the direct interactionof the different
be localized within themembrane at a similar depth as
complexes of the respiratory chain includes the isolation of
center i.
1:III and 1I:III supercomplexes (10,111, the presence of the
two small subunitsof succinate-ubiquinone oxidoreductase in
the cytochrome b-cl complex after removal of succinate dehydrogenase by alkali (12), and the specific interaction beThe mitochondrial respiratory chain is
considered to be
composed of discrete lipid-protein enzyme
complexes, each of tween complexes I1 and I11 (13). In a n earlier study (6), we
which catalyzes a distinct part of the overall oxidation reacThe abbreviations and trivial names used are: Q(H2), ubiquinol
tion. Ubiquinone, by virtue of its stoichiometric abundance, (reduced
ubiquinone); b-c, complex, mitochondrial ubiquinol-cytoits hydrophobicity, andsmall molecular weight, hasbeen
chrome c oxidoreductase; Qo, ubiquinone without a side chain; Q l , Q2,
*This workwas supported, inpart, by National Institutes of
Health Grant GM-38433. The costs of publication of this article were
defrayed in part by the payment of page charges. This article must
therefore be hereby marked “aduertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
$ T o whom correspondence should be addressed.

QB,ubiquinone with side chains containing 1,2, and6 isoprene units,
respectively; DB, 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone;
DQ, duroquinone, 2,3,5,6-tetramethyl-1,4-benzoquinone;
MQ, menadione, l,-l-naphthoquinone, vitamin KO;
vitamin K,, 2-methyl-3-phytyl-1,4-naphthoquinone;
2,3,6-trimethyl-1,4-benzoquinone;
PQoClo,2,3-dimethyl-6-decyl-l,4-benzoquinone;
PQ2, plastoquinone2.
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TABLEI1
Reduetion of erogenous quinones by succinate and the inhibition by antimycin and rnyxothiazol
Mitochondria (concentration of cytochrome c, 0.016 pM) were incubated with quinones in the standard buffer
for 5 min in the presence of 1.6 mM KCN and the reaction started by addition of 2 mM succinate. Antimycin (2
p ~ and
) myxothiazol (2 p ~ )when
,
used, were added to the standard buffer immediately after the mitochondria.
In calculating the specific activities, it was arbitrarily assumed that the extinction coefficient in buffer at all
wavelength pairs is 8 mM” cm”. This value will give approximate, but nevertheless, close values to the specific
activities and will not affect the percentage of inhibition. The concentrations of the quinones were: DQ, QO,Q2,
DB, MQ, PQ~elo,and PQ2,40 pM;Q1, 22 p M ; PQhl, 112 p ~Stimulation
.
of activity is expressed by a negative sign.
Inhibition ( W )
Quinone

Wavelength
pairs

~~

Activity
(nmol Q min” mg”)

Antimycin
Antimycin

+

Myxothiazol

myxothiazol
M”

W

M

W

M

W

nrn

65
266-290
1.5
7.0
55
268-290
1.2
10.8
95
6
1
275-290
1.1
13.9
6 2
275-290
16.4
18.8
0
0
DB
279-290
18.0
-23 15.6
-9
0
0
264-290
MQ
Vitamin K,
264-290
0
0
260-280
1.3
21.9
71
P Q ~ I
-36
PQom
260-280
1.7
16.5
-72
PQ2
260-280
0.9
14.8
M and W refer to mutant (Q-deficient) and wild type mitochondria.
DQ

Qo

proposed an interaction between complexes I1 and I11 based
on theantimycin-sensitivity of DQ and plastoquinone reduction by succinate in submitochondrial particles and isolated
succinate-cytochrome c reductase.
The current study provides further evidence for the direct
interaction between the primary dehydrogenases and the cytochrome b-cl complex in the reduction of several quinones
and quinone analogues in both wild type and ubiquinonedeficient yeast mitochondria. In addition, the inhibition of
quinone reduction by antimycin with succinate as substrate
and by myxothiazol with NADH as substrate suggests that
succinate-Q oxidoreductase specifically interacts with center
i andNADH-Q oxidoreductase preferentially with center o of
the cytochrome b-cl complex. Since the NADH dehydrogenase involved in quinone reduction has been shown to face the
matrix side of the innermembrane, we also suggest that center
o may actually be localized in the center rather than on the
outer side of the membrane.
MATERIALS ANDMETHODS
RESULTS~

Reduction of Exogenous Quinones by Succinate-The rates
of reduction of various exogenous quinones by succinate observed in mitochondria isolated from both wild-type and Qdeficient yeast cells and the sensitivity of the reactions to
antimycin and myxothiazol are summarized in Table 11.
The reduction by succinate of the “small” quinones: DQ,
Qo, Q1, and PQocl in wild type mitochondria was significantly
inhibited by antimycin, but was essentially insensitive to
myxothiazol. Similar results were previously reported with
DQ as substrate in pig heart mitochondria (6). The reduction
of PQ&loand PQ2by succinate in wild type mitochondria was
also largely inhibited when both antimycin and myxothiazol
were present, but antimycin or myxothiazol alone had little
Portions of this paper (including “Materials and Methods,” part
of “Results,” Tables I and VI, and Fig. 1) are presented in miniprint
at the end of this paper. Miniprint is easily read with the aid of a
standard magnifying glass. Full size photocopies are included in the
microfilm edition of the Journal that isavailable from WaverlyPress.

0
-9
0
0
-23

-

-6
22
-30

M

-

W

-1
-10

75
77
87
0
14

-

73
93
97

-

-

-

or no effect. Previously, we had reported that in pig heart
mitochondria succinate could reduce PQ2 in an antimycinsensitive reaction and PQocloin a reaction sensitive to the
combined effects of myxothiazol and antimycin (6). These
results suggest that the pathway of electron transfer from
succinate to these small quinones must involve the cytochrome b-cl complex where these inhibitors specifically act.
A much slower rate of reduction of all these quinones by
succinate was detected in Q-deficient mitochondria suggesting
that endogenous ubiquinone is required for the reduction by
succinate of all plastoquinone-type quinones and the ubiquinone-type quinones without a side chain or with a side chain
not longer than 5 carbons?
By contrast, the reduction of DB and Q2 occurred at a
similar rate in both wild type and Q-deficient mitochondria,
and was not sensitive to antimycin or myxothiazol or their
combined use. Succinate dehydrogenase must thus directly
reduce these compounds probably by the same pathway involved in the reduction of endogenous quinones.
Menadione and vitamin K1,due to their low mid-point
potentials, could not be reduced by succinate by either mitochondrial preparation.
Reduction of Exogenous Quinones by NADH-When
NADH was usedas thereductant instead of succinate, major
differences were observed (Table 111). 1) The quinone reduction rate was 10-20 times faster than that observed with
succinate as electron acceptor. The observed faster rate of
quinone reduction by NADH compared to succinate may
reflect the presence of two NADH dehydrogenases in yeast
mitochondria. It should be noted, however, that the rate of
NADH-DQ oxidoreductase in beef heart mitochondria was
346 nmol of Q min” mg” (Fig. 2 ) , a value comparable to that
observed with yeast mitochondria. 2 ) The reduction of the
small quinones: DQ, Qo,Q1, and PQocl wasnot or only slightly
inhibited by antimycin, but was significantly inhibited by
myxothiazol. The sensitivity to myxothiazol was greater with
the Q-deficient (55-75%) than with the wild type mitochon3) reduction of these quinones as well as
dria (40-50%). The
PQo,lo and PQ2 no longer required endogenous Q6. When the
Zhu, Q. S., and Beattie, D. S., submitted for publication.
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TABLE
111
Reduction of exogenous quinones by NADH and the effect of antimycin and myxothiazol
The experimental conditions and the calculation of specific activities were the same as in Table I1 except that
the cytochrome c1 concentration was 0.004 phi and 50 phi NADH replaced succinate. When the specific activities
was
were calculated from NADH oxidation monitored at 340-380 nm, an extinction coefficient of 5 mM"cm"
used.
Inhibition (%)
Quinone

Activity
Q min" mg") Myxothiazol

Wavelength
(nmol
pairs

91
Qz

262

355

DB
MQb290
Vitamin

PQ,,
PQocm
PQz340

+

myxothiazol
M"

DQ270
90240

Antimycin
Antimycin

W

M

340-380
169
0
270-247
135
13
270-247
301
171
14
340-380
488
370
0
340-380
360
165
0
340-380
12
K,
340-380
0
0
340-380
300
173
0
-3
340-380
87
137
340-380
M and W refer to mutant (Q-deficient) and wild type mitochondria.
In the wild type the wavelength pair 270-247 nm was used.

270-2C7 nm
+anti.
+ myxo.
+myxo.

2Osec

control
FIG. 2. Reduction of DQ by NADH in beef heart mitochondria. The experimental conditions were the same as in Table 111,
except that beef heart mitochondria (cytochrome c1 concentration,
0.016 hi) replaced yeast mitochondria.

small quinones were used as electron acceptors, the reduction
rate was fasterin the mitochondria from the Q-deficient
mutant than inthose from the wild type cells suggesting that
the presence of Q6 was actually inhibitory to thereduction of
exogenous quinones. One explanation is that the diffusion of
endogenous Q from the dehydrogenase to the b-cl complex is
the rate-limitingstepinthis
reaction. 4) Menadione was
reduced at the similar rate as the other small quinones and
with the same pattern of inhibition. However, vitamin K,, a
naphthoquinone with the same ringas menadione and a
phytyl side chain similar in structure to that of Q3, could not
be reduced by NADH either in the wild type or Q-deficient
mitochondria. 5) The reduction of PQoCloand PQz was 4050% inhibited by myxothiazol in wild type mitochondria but
lacked such sensitivity to myxothiazol in the Q mutant. It
should be noted that the reduction of PQo,,o proceeded at a
much slower rate than that of PQ,. 6) The reduction of DB
and Q2in both wild and Q mutant
mitochondria was inhibited

W

M

W

8
19
17
0
19
8

6969
62
82
15
20
75

43
40
78
21
32
38

63
42
10
12
76

63
40
100
30
36
54

10
0
0

53
0
0

34
37
50

53
0
-6

52
40
51

W

M

20-30% by myxothiazol. It should be recalled that thereduction of these quinones by succinate was not inhibited by either
antimycin or myxothiazol. These results indicate that the
reduction of various analogues of ubiquinone by NADH also
involves electron transfer through the cytochrome b-cl complex and that the sensitivity to antimycin and myxothiazol
depends on the substrate used. We suggest that these results
can be explained by direct protein-protein interactions between the primary dehydrogenases and the cytochrome b-c,
complex.
The Sideness of the NADH Dehydrogenase Which Is Responsible for the Myxothiuzol Sensitivity-In yeast, there is a
single succinate-Q reductase located on the matrix side of the
mitochondrial inner membrane. Two different kinds of
NADH-Q reductase, however, are present in yeast mitochondria. One reductase is located at the matrix side while the
other is located on the cytoplasmic side of the membrane;
however, both reductases interact with the b-c, complex
through the Q pool (21). Identification of the NADH-Q reductase which is responsible for the myxothiazol-sensitive
reduction of small quinones may suggest a location in the
membrane for center 0 , where myxothiazol has been shown
to act (22). In the experiments described previously in this
paper, mitochondria were obtained by breaking yeast cells
with glass beads, and hence may have become fragmented.
Indeed, significant succinate-Q reductase activity was observed after addition of the impermeable substrate, succinate.
Therefore NADH added externally to such mitochondrial
preparations would be accessible by both NADH-Q reductase
complexes. To differentiate the two NADH-Q reductases,
yeast mitochondria were prepared from spheroplasts obtained
by incubating yeast cells with zymolyase (16). Mitochondria
prepared after zymolyase treatment showed low succinateferricyanide and succinate-DQ activities indicating that succinate was not available to the enzyme and that the mitochondria were intact (Table IV). In the same mitochondria,
however, there was a very high NADH-ferricyanide activity
(950 nmolFe3'/min/mg),which
can be attributed to the
enzyme on the outer surface of the membrane. The rate of
DQ reduction by NADH in thezymolyase-prepared, and thus
intact mitochondria, was approximately half that observed
with broken mitochondria, and was not inhibited by myxo-
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thiazol (Table IV). In addition, no sensitivity to myxothiazol peptide. To see if the direct interaction with the 6-~1
complex
was observed when Qo, PQoCl,and menadione were used as is limited to small primary dehydrogenases such as succinate
electron acceptors. However, when the reduction of these Q dehydrogenase and the NADH-Q reductase in yeast, the reanalogues was studied in submitochondrial particles, prepared duction ofDQby
NADHwas also studied in beef heart
from the same mitochondrial sample, sensitivity to myxothia- mitochondria. These mitochondria containa 12 subunit,
zol was apparent (Table IV). These results indicate that the transmembrane NADH-Q reductase with a site for energy
NADH-Q reductase on the outer surface of the inner mem- coupling. Furthermore, in beef heart mitochondria, the oxibrane can directly reduce DQ and the small analogues, but dation of NADH occurs strictly from the matrix side of the
that the NADH-Q reductase localized on the matrix surface membrane. The mitochondria used in these studies were
of the membrane reduces them indirectly by electron transfer prepared by breaking beef heart muscle cells with a blender
through the cytochrome b-cl complex. Since these data sug- (19) and hence are sufficiently damaged for NADH to reach
gest that center o is accessible to the enzyme located at the its reaction site on the enzyme. It can be seen from Fig. 2
inside of the membrane, the postulated location of center o that the reduction ofDQ by NADHwashighly sensitive
toward the outside of the membrane may need to be reevalu- (74%)to myxothiazol and somewhat sensitive (28%)to antiated.
mycin. The results with inhibitors indicate that the large
Duroquinone Reduction by NADH in Beef Heart Mitochon- mammalian enzyme complex also interacts directly with the
dria-Yeastlack
site I of oxidative phosphorylation (23) cytochrome 6-cl complex.
suggesting that the two NADH dehydrogenases are possibly
The Dependence of the Sensitivities to Antimycin and Myxosmaller, less complicated enzymes than their counterparts in thiazol on Temperature-The sensitivity of reduction of the
mammalian mitochondria. Indeed, the NADH-Q reductase of small quinones by NADH and succinate to inhibitors of the
yeast isolated by deVries (24) is composed of only one poly- 6-cl complex suggests that the pathway of electron transfer
must involve the reaction sites of this complex, where these
TABLEIV
inhibitors have been shown to interact. Furthermore, the
Comparison of reactions and sensitivities to myxothiazol in different
dependence of the sensitivity on the substrate used, to antiyeast mitochondrial preparations
mycin when succinate was the reductant and to myxothiazol
The methods of preparation ofmitochondria and submitochondria when NADH was used, suggests that the reduction of the
particles are described under "Materials and Methods." The experi- small quinone molecules may occur through a specific and
mental conditions were the same as in Table 111.
direct interaction between the dehydrogenases and the 6-~1
Mitochondrial preparation
complex. For example, the NADH dehydrogenase on the
Glass
Zymolyase
Submitomatrix side of the membrane may interact primarily with
beads
digestion
chondrial
center 0,while succinate dehydrogenase may interact primar(broken)
(intact)
particles"
ily with centeri of the b-cl complexvia protein-protein
Succinate-ferricyanideb
119
21
interactions between the complexes. Such interactions would
Succinate-DQ'
14
0.9
result from the movement of enzyme complexes in the memNADH-DQ'
NDd
98
74
brane and hence should be temperature dependent.
Sensitivity to myxothia201 (%)
Table V shows that lowering the temperature from 30 to
43
0
36
NADH-DQ
14.5 "C greatly increased the antimycin inhibition of DQ and
NADH-Qo
40
0
28
Q, reduction by NADH in the Q-deficient mutant; however,
NADH-MQ
54
0
34
such an increased antimycin sensitivity was not observed in
"Prepared from mitochondria isolated from yeast cells digested wild type mitochondria. By contrast, this temperature dewith zymolyase.
crease had only a small effect on the degree of myxothiazol
* Nanomole of Fe(CN)-3 reduced min" mg".
inhibition of NADH reduction of these quinones in Q-defiNanomole of DQ reduced min" mg".
cient mitochondria, but essentially abolished the myxothiazol
ND, not determined.
TABLE
V
The effect of temperature
on the sensitivities of the reduction of Qo and DQ to antimycin andmyxothiazol
The experimental conditions were the same as in Tables I1 and 111 for succinate and NADH as substrate,
respectively. The reduction of DQ and QOwas monitored at 270-247 nm.
Sensitivity (%)
Activity
(nmol Q min" mg")

Temperature

Quinones

M"

Antimycin
Antimycin

W

M

100
2
127
-3 128
43 168

47
3
63
79 20

W

Myxothiazol
M

+

myxothiazol

W

M

W

0
32

79

46
64
30

"C

NADH as substrate
204

Qo

DQ

240

14.5
30.5
14.5
63
30.5

69

7
85

254
154

8

74 64
92

1

Succinate as substrate
14.5
30.5
14.5
30.5

Qo

8.4

DQ
7.0
a

-4

2.6

84

3.6

66
46

M and W refer to mutant (Q-deficient) and wild type mitochondria.

93

100
-3
0

100
91
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sensitivity in wild type mitochondria. A surprising observation was that the large temperature decrease (15.5“C)had
only a slight effect (20-30% decrease) on the rate of electron
transfer from NADH to DQ and Qo (Table V).
For the studies with succinate as the reductant, only the
wild type mitochondria were used as the Q-deficient mitochondria cannot catalyze the reduction of DQ and Qo (Table
11). The drop in temperature significantly increased the
amount of antimycin inhibition, and the reaction was completely inhibited by the combined use of antimycin and myxothiazol. Moreover, the rate of reduction ofDQ and Qoby
succinate was lowered 2-3-foldby the temperature change.
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dria that lack endogenous Q6. For example, the reduction of
DQ by DQH2formed by the primary dehydrogenases will not
create more DQH, molecules. Consequently, the reduction of
DQ which is antimycin- and myxothiazol-sensitive must involve the transfer of electrons from the dehydrogenases directly to DQ on the cytochrome b-e, complex. Similar reasoning can explain the reduction of dichlorophenylindophenol by
NADH in the mitochondria lacking ubiquinone.
In general, the sensitivity of Q2 and DB reduction to antimycin and myxothiazol was low or not detectable suggesting
that these quinones can interact directly with the primary
dehydrogenases as do the endogenous quinones. The high
concentrations of these analogues used in these experiments
DISCUSSION
would also favor a direct interaction. Protein-protein interThe results of the present study suggest that protein-pro- actions, however, may well play a role in their reduction as
tein interactions between the primary dehydrogenases and evidenced by the 20-30% inhibition by myxothiazol in both
the cytochrome b-cl complex are involved in thereduction of wild type and Q-deficient mitochondria when NADH wasthe
exogenous quinones. Furthermore, the myxothiazol sensitiv- substrate. As discussed previously (9), direct protein-protein
ity of quinone reduction by NADH suggests that NADH-Q interactions in electron transfer to quinones becomes imporoxidoreductase preferentially interacts with center 0, while tant only when most of the quinone molecules are bound.
Protein-protein interactions may occur through diffusionthe antimycin sensitivity of the reduction by succinate suggests that succinate-Q oxidoreductase interacts preferentially based collisons, as thediffusion rate of the various complexes
in the mitochondrial membrane has been calculated to occur
with center i.
Theoretically, exogenous quinones could be reduced by the more rapidly than electron transfer (2, 3). Alternatively, the
mitochondrial respiratory chain by any of the following pos- complexesmay occur in aggregated form (7, 8). Our data
sible mechanisms: 1)direct electron transfer from the ubiqui- cannot distinguish between these two models.
The preferential interaction of center i and o with succinate
none reducing site on the primary dehydrogenases; 2) from
endogenous Q6H2formed by the primary dehydrogenases; 3) and NADH oxidoreductases, respectively, suggests that these
on center i and/or center o of the cytochrome b-cl complex centers must each have different chemical properties as well
with free Q6HZ as the electron donor; 4) on center i and/or as physical identities composed of different amino acid resicenter o of the cytochrome b-c, complex but with the electrons dues on the same or different subunits of the complex. Moredonated directly by the primary dehydrogenases through pro- over, each center must be located at different sites on the
cytochrome b-c, complex. The specific interactions proposed
tein-protein interactions between these complexes.
The first mechanism represents the “classical” pathway of in the current study may offer an important clue as to the
electron transfer and does occur as evidenced by the antimy- actual location of the two centers, especially center 0,in the
cin- and myxothiazol-insensitive rate of quinone reduction; inner membrane. The localization of succinate dehydrogenase
however, this mechanism cannot explain the observation that at the matrix side of the inner mitochondrial membrane in
quinone reduction is largely blocked by specific inhibitors of both mammalian and yeast mitochondria is consistent with
the cytochrome b-cl complex. The second mechanism requires the localization of center i at this side of the membrane where
direct quinol-quinone electron exchange without the involve- succinate-Q oxidoreductase and the cytochrome b-cl complex
ment of protein which Rich (25) has shown to occur too slowly might interact.
By contrast, the generally accepted localization of center o
to explain the observed rates. Quinol-quinone reactions would
also be insensitive to antimycin and myxothiazol. The third (0referring to outer)on the outer side of the inner membrane
mechanism involving the reduction of exogenous quinones in close proximity to the iron-sulfur protein and cytochrome
with free QBH2may occur to some extent; however, this el (26) is inconsistent with the interaction of this center with
mechanism fails to explain why quinone reduction is largely NADH-Q oxidoreductase. Thesubstrate oxidizing site of
antimycin sensitive with succinate as electron donor and mammalian NADH-Q oxidoreductase has been shown to face
mainly myxothiazol sensitive with NADH as electron donor. the matrix, while the results of the current paper demonstrate
It may be argued that the QsH2 formed by NADH-Q oxido- that the yeast NADH dehydrogenase facing the matrix is
reductase goes preferentially to center o and that formed by involved in the myxothiazol-sensitive (center 0) reduction of
succinate-Q oxidoreductase to center i, but such apathway is small quinones. These results strongly suggest that center o
not consistent with the homogenous reduction kinetics of the may indeed be located far from the outer surface of the
membrane, possibly near the center of the membrane. Placing
Q pool observed in thepresence of a single substrate.
The fourth mechanism involving specific interactions be- center o at the center of the membrane is consistent with
tween the primary dehydrogenases and the cytochrome b-e, physical studies which have indicated that ubiquinone molecomplex not only explains the substrate-dependent sensitivi- cules are located at the central region of the phospholipid
ties to inhibitors of the b-c, complex, but also gives a possible bilayer (27).
explanation to the large differences in the rates of reduction
Furthermore, NADH-Q oxidoreductase can also interact
of the small quinones with NADH and succinate as electron with center i as indicated by the partial sensitivity to antidonors. The quinone-reducing site on NADH-Q oxidoreduc- mycin of the NADH reduction of the small quinones. The
tase, possibly due to themore negative midpoint potential of interaction of NADH-Q oxidoreductase with both centers o
NADH compared to succinate, mayhave a much greater and i suggests that the two centers maybelocalized at a
reducing capacity to the quinones on the Q-reacting sites of similar depth in the membrane especially if the movement of
the cytochrome b-cl complex.
enzyme complexes occurs mainly in the plane of the memProtein-protein interactions are also necessary to explain brane without much movement perpendicular to the memthe reduction of small quinones in the Q-deficient mitochon- brane. Such a localization is also consistent with the semi-
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quinone model for electron transport in the cytochrome b-cl
complex which proposes a ubiquinone pocket localized between centers o and i (28). The suggestion that center o might
be far from the outer surface of the membrane is also supported by previous results from our laboratory suggesting that
subunit VII, the Q-binding protein, is involved in electron
transport at center o but faces the matrix side of the membrane (29).
The effects of lowering the temperature on the rates of
quinone reduction and on the degree of inhibition by the
specific antibiotics suggest that endogenous quinone affects
the interactions between the dehydrogenases and the cytochrome b-cl complex. NADH-Q appears to interact more
tightly with the b-cl complex, especially with center i in Qdeficient compared to wild type mitochondria as evidenced by
the increased antimycin sensitivity at thelower temperature.
In the wild type mitochondria, the endogenous ubiquinone
may hinder the interaction of NADH-Q reductase with center
i as evidenced by the low antimycin sensitivity at either
temperature and the decreased sensitivity to myxothiazol at
the lower temperature. Succinate-Q oxidoreductase in thewild
type mitochondria appears to interact more tightly with the
cytochrome b-cl complex at lower temperatures as indicated
by the increased sensitivity to antimycin and the 100% inhibition by antimycin plus myxothiazol at 14.5 "C. Hence, lowering the temperature may result in changes in the distance
between the complexes or in the depth of their Q-reacting
sites in the membrane.
Another important conclusion from this work is that each
of the primary dehydrogenases have different structural requirements for their interactions with the different quinones
and quinone analogues. Previously, we reported that the reduction of DQ by succinate requires endogenous ubiquinone
or ubiquinone homologues with an alkyl side chain containing
a minimum of two isoprene units.3 The data of the current
paper extend this observation and suggest that all quinones
with a plastoquinone-type ring as well as ubiquinones with a
side chain not more than 5 carbons long require endogenous
quinone for their reduction by succinate dehydrogenase. In
addition, the reduction of these analogues by succinate is
highly sensitive to inhibitors of the cytochrome b-cl complex
suggesting that even in the presence of endogenous quinone,
these quinones do not react directly with succinate-ubiquinone oxidoreductase. It is still notclear which of the threeQreacting sites, center0,center i, or that on succinate dehydrogenase requires endogenous ubiquinone.
NADH-Q oxidoreductase, on the other hand, appears to
tolerate considerable changes in theside chain and ring structure of the quinones. The antimycin- and myxothiazol-insensitive rates of quinone reduction are high (as is the total
reduction rate) indicating that thisenzyme can directly reduce
all of the quinones tested with the exception of vitamin K1.
Endogenous Q6 is not required for the direct reduction of
these quinones. Indeed, its presence is actually inhibitory
indicating that the quinone reductions occur through the Qreacting site on NADH dehydrogenase without the mediation
of Qo.
The results obtained with Q1 were unexpected. The rate of
Ql reduction by either succinate or NADH was greater than
that of Qo or DQ and similar to that of Qz or DB suggesting
that Q1may interact with the primary dehydrogenases in a

similar manner as theseanalogues. However,the reduction of
Q1 by succinate required the presence of endogenous quinone
and was inhibited 95% by antimycin while its reduction by
NADH was inhibited 82% by myxothiazol suggesting that Q1
interacts with the respiratory chain in the same manner as
Qo or DQ. We thus conclude that Q1 is a poor choice to use
for a replacement of Q6 when studying reaction mechanisms
of ubiquinone in the electron transfer chain of yeast mitochondria.
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Hateriais and Hethods
The protorrophic strain,
0273-108 and the ubiquinone
(Q)-defieient straln. E3-24
(141, were obtained from Dr. Alexander Tzagoloff. The cells were g ~ o mareoblcally at 30'
In semisynthetic medium ( 1 5 ) containing 31 galactose PI carbon ~ D U ? Cand
~
harvested at the

late iogarlthmlc p h a ~ eo f gPouth.

Mitochondria sere obtained by two methods: one involves

breaking cell9 with glass bead9 In the Wnomill (Ehu and Bealtlea).

In the Ofher method

mitochondria were pFepaPed from SpheroplaSts obtained by treating the cells with symolYaJe
as describsd by Gasse3

(161.

intact and

for

used

thus

The mitochondria

prepared by the latter method were
of

Lhe determination of thesidene33

WPe

the dehydrogenases.

Submitochondrial particles were prepared I n 0.1 M potasalum phosphate buffs?. pH 7.5, Con-

Table I

talning 0.1 mU EDTA according to Clejan st al. (17). Mitochondria obtained from atrain
E3-24 Yere ahom t o have no detectable ubiquinone In Spectra o f ether-methanol C X f r P C t J

Spectral Analysis of Qulnonss

(1

Beef heart mitochondria YePe prepared according t o Crane et a l . (19).

8).

ell enzymatic reactions were performed in 50

Trls-HC1
buffer. pH 7.4. containlng 250 mM S Y C P O S ~ and 1 mH EDTA using an Aminco-DW2C double bean
dual wavelength rpeclrophotometer LherMSCated
a t 25OC.
The wavelength pairs used for
monitoring qulnone reductionil by different SubSLPLteJ rill
be Peported in the Rtt(lult3
section.
Unless otherwise stated,

LPM

Antlmyycln, CQ, menadione (vitamin K3) a n d 2-oethyl-3-phytyl-l14-naphrha9uinone
(Vitamin K I I were purchased from Sigma and myxoChiazoI from Boshringer Haanhelo. 91 and
Q2 (ubiquinone -1-21 Were a genePous g i f t from Hoffman LaRoche. DB was prepared according

90, PQOcl,PQocl0 and PO2 (methyl and decyl analogue O f PlartWuinOne)
synthesized I n the laboratory of Dr. L . Q . Cu as previously reported (6). All these

to Ua(argoll3 ( 2 0 ) .
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chamlcalz "ere
p'epared

with

addsd to the reaction mixture as ethanol solutlon~ when mitochondria
the W n o n i l l or rubmitachandrialparticles
lacked ethanol dehydrogenase aCtiviLy.
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high
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med.

Both of
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Menadione
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264-290
340-380
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275-210,
340-380
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ethanol dehydrogenase activity.
Uitochondria

Therefom, the 0xOgenou11 analogues w e ~ eadded ail dimethyl aulfoxide solutiona.
was purchased

TDe posltion of the negative peak o f quinonea in their redox difference Spectra In
ethanol and the YBYelength pairsused f o r the detection of thelr m d u c t i a n by SYCCiIIBtO OP
NADH. In all the expari.snts 1.6 KCN wa3 Included to pPavent aridation of the reduced
quinones by the respiratory chaln.
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261, 269
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pQOcl* p p O e l O ~ pQ2
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the h i g h e ~ tpurity
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Inhibition of dlehloroindophonol (DCIPI reduction In Yeast mltoehondria br antiwycln and
myxothiasol.

DCIP,

artirieial

an

of

electron
acceptor

the
Pria8ry
flavoprotein

dehydrogenaasa, is believed to Interact with the mitochondrial respiratory chain throush
bound quinone, 1.8..
%coinate

through the YbiqUinOne-reaCting

EeDteP8.

The reduction

Of

DCIP bY

in rlld type yeaat mltochondrla war inhibited 742 by antimycin and 462 by my-

Furthermre, the reduction of DCIP WBS almost completely inhibitad
in the p~esencs ofboth antimycin and myxothisral sugge3ting that the YblquinOl bound to
~uooinste dehydrogenase in the membranecannot
tranafer e 1 e c t ~ O n S to DCIPYithoUt

xothiaeol (Table VI).

Involving both CenteP

1

and center 0 of the cytochrome k-2, complsx.

AI anticlpatad,

mitochondria from the Q-deflclent yeast could not reduce DCIP.
and Qdaflclsnt
In the presence o f NADH, OCIP 11I8 reduced by both rild type
nltochondria; hoYevar, the rate o f reduction r a a a l m s t double in the mitochondria laioking
ubiquinone.
In both wild-type and 9-deflolsnt mitochondria, the Pate or K I P mductlon
vas innlbltsd Mderately by myxOthlaz01 and by antimycin.

dehydrogenase can dlrectly reduce

These result3 SUBBaat that NADH

OCIP in a rtlaction promoted by endogenouI 96 and that

the ubiquinol produced by NADH dehydrogenase

0%"

8130 transfer electrons to KIP t h m u g h

the antimycin and oyxothiarol sensitive site3of the ~ytoch~orne
1-2,CoOp1111.

Table VI
Inhibition Of DCIP Reduction By Antimycin And Myxothlazal
HitoChOndrla ( 0 content 0.008 u M and 0.016 Y M for NADH redwtlon and Juceinlltc
Peductlon rerpsctlus~y)were incubated with 50 u M K I P in Standard buffer f o r 5 ain in the
p~esenceof 1.6
KCN. Then 2 mH Succinate OP 50 YM NADH was addsd to start tha
Peaotion. The Pddmtlon of DCIP nltored
using the wavelength palr 600-630 nm. An
extinction coefficient of 0.9 mPT~3'was used to CalCulste activity.
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